Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Immunosuppressive 2-acylquinolines developed by Japanese lab

June 19, 2000

Nexell obtains exclusive license to Diaclone antibody portfolio

June 19, 2000

Chiron and Norwegian National Institutes of Public Health formalize meningitis agreement

June 19, 2000

Synthetic peptide enhances the microbicidal activity of monocytes

June 16, 2000

Phase I clinical trial begins for Cantab's cervical dysplasia vaccine

June 16, 2000

AdProTech enters collaboration with PowderJect for DNA vaccine program

June 16, 2000

CpG oligodeoxynucleotides for enhancing immune response: NIH offers license

June 16, 2000

Merck presents new inhibitors of Kv1.3 and Kv1.5 channels

June 15, 2000

Novel IK(Ca) channel inhibitor presented at ASBMB/ASPET 2000 by UCI

June 15, 2000

Merck presents two new series of potassium channel blockers for autoimmune diseases, arrhythmias

June 14, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.